abstract: Patients carrying a chromosomal rearrangement (CR) have an increased risk for chromosomally unbalanced conceptions. Preimplantation genetic diagnosis (PGD) may avoid the transfer of embryos carrying unbalanced rearrangements, therefore increasing the chance of pregnancy. Only 7-12 loci can be screened by fluorescence in situ hybridization whereas microarray technology can detect genome-wide imbalances at the single cell level. We performed PGD for a CR carrier with karyotype 46,XY,ins(3;2)(p23;q23q14.2),t(6;14)(p12.2;q13) using array comparative genomic hybridization. Selection of embryos for transfer was only based on copy number status of the chromosomes involved in both rearrangements. In two ICSI -PGD cycles, nine and seven embryos were analysed by array, leaving three and one embryo(s) suitable for transfer, respectively. The sensitivity and specificity of single cell arrays was 100 and 88.8%, respectively. In both cycles a single embryo was transferred, resulting in pregnancy following the second cycle. The embryo giving rise to the pregnancy was normal/balanced for the insertion and translocation but carried a trisomy 8 and nullisomy 9 in one of the two biopsied blastomeres. After 7 weeks of pregnancy the couple miscarried. Genetic analysis following hystero-embryoscopy showed a diploid (90%)/tetraploid (10%) mosaic chorion, while the gestational sac was empty. No chromosome 8 aneuploidy was detected in the chorion, while 8% of the cells carried a monosomy for chromosome 9. In summary, we demonstrate the feasibility and determine the accuracy of single cell array technology to test against transmission of the unbalanced meiotic products that can derive from CRs. Our findings also demonstrate that the genomic constitution of extra-embryonic tissue cannot necessarily be predicted from the copy number status of a single blastomere.
Introduction
In 5-10% of all couples suffering recurrent miscarriages, one of the partners is carrying a balanced chromosomal rearrangement (CR) which is at least a 30-fold increase compared with the general population (Fryns and Van Buggenhout, 1998; Celep et al., 2006) . Furthermore, it is well established that carriers of balanced CRs have a higher risk of producing offspring carrying unbalanced chromosome complements, since meiotic pairing of the homologous chromosomes involved in the rearrangement cannot occur in a simple linear fashion (Scriven et al., 1998; KaiserRogers and Rao, 1999; Weier et al., 1999) . In case of a reciprocal autosomal translocation, the two derivative chromosomes and their normal homologues form a quadrivalent. Only alternate 2:2 segregations yield chromosomally balanced gametes. Adjacent 2:2 segregations will produce gametes with partial trisomies and monosomies. Also 3:1 and 4:0 segregations can occur, resulting in trisomies and monosomies or tetrasomies and nullisomies, respectively (Kaiser-Rogers and Rao, 1999) . Interchromosomal insertions, on the other hand, with a long inserted segment may form a quadrivalent containing an insertion loop (Kaiser-Rogers and Rao, 1999) . If no, or an even number of, crossovers occur within the insertion loop, the consequences are the same as for non-paired bivalents. If an odd number of crossovers occur in the insertion loop, however, recombinant chromosomes that would lead to production of gametes with duplications and deletions may be formed (Kaiser-Rogers and Rao, 1999) . For reciprocal translocations as well as interchromosomal insertions, the risk of having a live born abnormal child will depend on the viability of the partial trisomies and monosomies produced (Kaiser-Rogers and Rao, 1999) .
Complex chromosomal rearrangements (CCRs) are defined as structural rearrangements involving more than two breakpoints. As a consequence, the apparently independent reciprocal translocation and interchromosomal insertion present in our patient in this case study can be considered a CCR. Carriers of a CCR are at an even higher risk for chromosome imbalances in their gametes (Escudero et al., 2008 ) and thus at a higher risk for spontaneous miscarriages or for an abnormal fetus.
Preimplantation genetic diagnosis (PGD) offered to carriers of balanced CRs has the potential to reduce the risk for spontaneous abortions, to minimize the chance of getting offspring carrying a chromosomal imbalance and to increase the chance of becoming pregnant by selecting against cleavage-stage embryos carrying unbalanced CRs (Otani et al., 2006 ; as reviewed by Wilton, 2005) . Currently this selection is performed using interphase fluorescence in situ hybridization (FISH) (Pierce et al., 1998; Munné et al., 2000) . The limitations of FISH are the obligatory family-specific preparation and the limited number of probes that can be hybridized simultaneously (Weier et al., 1999; Bahçe et al., 2000) . In case of a simple two-way terminal reciprocal translocation, at least three probes, one for each translocated segment and one of the centric segments, are recommended (Scriven et al., 1998; Weier et al., 1999) . For carriers of a CCR, two or three consecutive multi-probe hybridizations on each blastomere have to be performed in order to highlight all potential unbalanced chromosome combinations in the embryo (Escudero et al., 2008) . Array comparative genomic hybridization (aCGH), on the contrary, is a genome-wide screening method in which non-amplified genomic reference DNA can be hybridized against differentially labelled single-cell DNA on a microarray slide Fiegler et al., 2007; Iwamoto et al., 2007; Hellani et al., 2008; Geigl et al., 2009; Vanneste et al., 2009a; Handyside et al., 2010; Johnson et al., 2010; Treff et al., 2010) . It has been shown that segmental imbalances as small as 8.3 Mb can be detected at the single-cell level using microarrays (Geigl et al., 2009) and that the array results can be obtained in only 48 h (Le .
In this study, we apply PGD based on use of array technology for a couple with fertility problems carrying a CCR, including a reciprocal translocation as well as an interchromosomal insertion, and determine the accuracy of bacterial artificial chromosome (BAC) aCGH.
Materials and Methods

Case report
A young couple (woman and man 27 and 32 years old, respectively), suffered three consecutive early spontaneous miscarriages. In all three miscarriages a fetal heartbeat was initially seen followed by spontaneous blood loss without further analysis. Karyotyping was performed on G-banded metaphase spreads of cultured lymphocytes using conventional methods. The woman had a normal 46,XX karyotype, while her husband was found to carry two CRs: an interchromosomal insertion whereby part of the long arm of chromosome 2 (2q14.2-q23) inserted directly into the short arm of chromosome 3 at band 3p23, as well as a reciprocal translocation between the short arm of chromosome 6 and the long arm of chromosome 14 with breakpoint at bands 6p12.1 and 14q13. The haploid autosomal length percentage for the inserted fragment was calculated to be 0.8%, while for the translocation it was 1.8 and 2.4% for the involved segment on chromosome 6 and 14, respectively. As not all chromosomal imbalances that could arise during meiosis as a consequence of these CRs would be detectable in two consecutive rounds of FISH, PGD using FISH was deemed inadequate. Hence, PGD via single-cell aCGH was suggested to this couple as an alternative, because all possible chromosomal imbalances were above our detection limit of 10 Mb (Fig. 1 , Vanneste et al., 2009a) . Following adequate counselling, both partners signed an informed consent, which was approved by the ethical committee of the University Hospital Leuven, to perform PGD using BAC aCGH at the single-cell level.
Hyperstimulation, oocyte retrieval, insemination, embryo culture, biopsy, transfer and vitrification Ovarian hyperstimulation and oocyte aspiration were performed as described (Vanneste et al., 2009c) . Single medium (Life Global medium, Ontario, Canada) was used for all cultures. All oocytes were ICSI-fertilized to avoid contamination during amplification (Sermon et al., 2004) . Normal fertilization was assessed by the presence of two pronuclei 16 -20 h after injection. Two cells were biopsied in the morning of Day 3 after fertilization as described (Vanneste et al., 2009c) . Each of the biopsied blastomeres were gently put in a 200 ml PCR tube containing 1.5 ml of alkaline lysis buffer as described . Embryo transfer was performed on Day 5 after fertilization. Fourteen to 18 days after oocyte retrieval, the b-hCG level was tested and was termed positive if ≥ 25 IU/l. Supernumerary embryos that were genetically normal for the investigated regions were vitrified according to the manufacturers protocol (Vitrifreeze, Fertipro, Beernem, Belgium) using the hemi-straw carrier system.
Array analyses
The single blastomere amplification, the BAC array and data analyses using Microsoft w Excel 2007 were performed as described Vanneste et al., 2009a and Le Caignec et al., 2006, respectively) . For the chromosomal fragments involved in the translocation and insertion, the mean and median of all consecutive clones per region ( Fig. 1) were calculated. A region for which the mean and median value were below 20.4 was considered deleted, while a region-specific value above 0.3 was scored as duplicated. All results were independently analysed by two experts in single-cell microarray data analysis.
Using Cytosure OGT 3.1.7, 15K Oligonucleotide array [Oxford Gene Technology (OGT)] analysis was performed according to the manufacturer's instructions.
Genetic analysis of the biopsied blastomeres
ACGH analysis of the biopsied blastomeres allowed us not only to analyse the chromosomes involved in the CCR, but also to analyse the copy number of all chromosomes. In this way whole chromosome and segmental imbalances could be identified genome-wide and as such broaden our insight in chromosomal (in)stability of early cleavage-stage embryos.
Transfer policy and ethical approval
A high rate of mosaicism is a well-known phenomenon in cleavage-stage embryos (Munné et al., 1994; Delhanty and Handyside, 1995; Kuo et al., 1998; Vanneste et al., 2009a) . We suggested that mosaic diploid/ aneuploid embryos may result in chromosomally normal fetuses, as we found the number of embryos that give rise to a successful pregnancy to be higher than the number of embryos that are normal diploid in every blastomere (Vanneste et al., 2009b) . Therefore, we decided in accordance with the ethical committee to base the selection of embryos for transfer only on the results of the chromosomes involved in the CCR. If multiple embryos were suitable for transfer based on the CCR, the final selection was based on the morphology of the embryo. Furthermore, the couple agreed to donate all embryos that were diagnosed as abnormal based on the chromosomes involved in the CCR for further research.
Hystero-embryoscopy, described by Beck et al. (2010) , is part of a study protocol in which couples suffering recurrent miscarriages can opt to participate. The study is aiming to identify loci that are necessary for early embryonic and fetal survival and is approved by the ethical committee. During hystero-embyroscopy a biopsy is randomly taken from the inner wall of the gestational sac (chorionic tissue) and from the embryo. Maternal contamination is examined by short tandem repeat (STR) analysis on the chromosomes 13, 18 and 21 using the kit 'DNA purify assay' (Multiplicon, Gent).
FISH and single nucleotide polymorphism confirmation
250K single nucleotide polymorphism (SNP) array copy number and loss of heterozygosity (LOH) analyses were performed on a selection of the biopsied blastomeres as described (Vanneste et al., 2009a) to detect imbalances on the chromosomes involved in the CCR as well as on the other chromosomes. Consequently, the SNP array analysis enabled confirmation of the BAC array results. Parent-of-origin analysis was performed as described (T. Voet et al., submitted).
FISH was used to confirm the CCR-derived imbalances on all nuclei of the remaining Day 5-embryos. For the latter analyses, performed as described (Melotte et al., 2004) , a combination of commercial and in house-labelled enumeration probe mixes was used. Commercial probes were from Abbott/Vysis: Centromere Evaluation Probe (CEP) 2 (D2Z1, Spectrum Orange, locus 2p11.1 -q11.1), CEP 6 (D6Z1, Spectrum Aqua, locus 6p11.1-q11), TelVysion 6q (Spectrum Orange, locus VIJyRM2158), CEP 8 (D8Z2, Spectrum Green, locus 8p11.1-q11.1), CEP 9 (Alpha satellite, Spectrum Aqua, locus 9p11 -q11), TCR/alfa delta (Spectrum Orange and Spectrum Green, locus 14q11.1-q11.2) and CEP X/Y (DXZ1, Spectrum Orange, locus Xp11.1 -q11.1 and DYZ1, Spectrum Green, locus Yq12).
The probe mixes which were labelled in-house were: for locus 2q37.3 a combination of Spectrum Green (Abbott/Vysis) labelled probes RP13-235N10, CTD-2192B23, RP13-555N08, RP11-637O03 and RP11-381P03; for locus 2q14.3 the Spectrum Orange (Abbott/Vysis) labelled probe RP11-11G20; for locus 6p25.3 a combination of Spectrum Orange (Abbott/Vysis) labelled probes RP11-572N11, RP11-488J04, RP11-16N09, RP11-717J18 and RP11-737K22 or Spectum Green (Abbott/Vysis) labelled probe CTB-62I11.
Results
Diagnosis of the chromosomes involved in the complex CR
The couple, in which the man was karyotyped as being 46,XY,ins(3;2)(p23;q23q14.2),t(6;14)(p12.2; q13) ( Fig. 1) , went through two ICSI -PGD cycles, summarized in Table I . During the first cycle, embryos 6, 7 and 8 were diagnosed as diploid for the chromosomes involved in the translocation and insertion. Embryo 6, morphologically scored as a 'very early blastocyst' at Day 5 after fertilization, was transferred, but no pregnancy was obtained. Embryos 7 and 8, both scored as morphologically abnormal at Day 5 after fertilization, were cryopreserved and later on donated for research. In the second cycle, embryo 3 was normal for the chromosomes 2, 3, 6 and 14 and was transferred. Positive b-hCG was detected. PGD using array comparative genomic hybridization Besides the CCR-derived imbalances confirmed in both biopsied blastomeres [embryos 3 and 10 from the first cycle and 1, 2 (Supplementary data, Fig. S1 ), 7 and 8 from the second cycle], additional mitotic or more complex events were detected in 6 out of 16 embryos. In the first cycle, embryo 1 suffered a double-stranded break in the maternal allele at the breakpoint of the insertion region (confirmed using SNP array) leading to an amplification from 2p terminal to 2q23.1 and a deletion from 2q23.1 to the end of the q-arm of chromosome 2. Embryo 2 was found to be mosaic normal/abnormal for the translocation region. In embryos 4 and 5 one blastomere showed a deletion of the insertion region and a diploid result for the rest of chromosome 2, whereas the second blastomere carried two copies of the insertion region and three copies of the remaining chromosome 2. SNP array analysis showed the presence of LOH in the insertion region of the latter blastomeres, suggesting a mitotic gain of a maternal chromosome 2, which was confirmed by the parent-of-origin analysis. Additionally, embryo 5 carried a trisomy for chromosome 3 in one blastomere and a trisomy 14 in both blastomeres. In the second cycle, embryo 5 carried a monosomy 6 and a trisomy 14 in both analysed blastomeres, while embryo 6 showed a duplication of 6p terminal in only one blastomere combined with a deletion of the insertion region in both blastomeres (Fig. 2) . The detailed BAC and SNP-array results of all embryos are reported in Table II .
Comparison of the BAC-and SNP-array results of the chromosomes involved in the CCR showed a discordance for six aberrations (Table II) . Four deletions of the inserted region and two duplications of the 14q13-qter segment were detected using the SNP-array, but missed using the BAC-array. FISH analyses confirmed all aberrations detected by array in six out of nine embryos, while for the other three embryos (embryos 5, 6 and 7 of the second cycle), only one of the two aberrations could be confirmed (Supplementary data, Table SI): the latter could be explained by self-correction mechanisms, such as trisomy -disomy conversions (embryo 5) or by mosaicism (embryos 6 and 7) (Mantel et al., 2007; Johnson et al., 2010; Thompson and Compton, 2010) .
Genome-wide analysis of the biopsied blastomeres by BAC-and SNP-array
An overview of all whole chromosome and segmental aberrations detected in the biopsied blastomeres on the chromosomes not involved in the translocation or in the insertion is given in Table III . Thirteen out of 31 blastomeres were found to be normal diploid for all autosomes not involved in the CCR. Eleven other blastomeres carried only whole chromosome aberrations, while three blastomeres carried only segmental aberrations. The remaining four blastomeres contained both whole chromosome and segmental aberrations.
Genetic analysis of the embryo following hysteroscopy
Embryo 3 of the second cycle was transferred and resulted in a pregnancy, despite the presence of a trisomy 8 and a nullisomy 9 in one of the biopsied blastomeres. However, at 7 weeks gestational age the diagnosis of a miscarriage was made as no fetal heartbeat was detected. A hystero-embryoscopy was performed to obtain the embryonic DNA for further analysis. 15K Oligonucleotide array analysis revealed genome-wide a normal diploid pattern. STR analysis excluded maternal contamination. FISH analysis of the chromosomes 2, 8, 9, X and Y showed a normal diploid signal in 84-93% of the 300 examined nuclei, while 4-14% of the nuclei were consistent with tetraploidy. This mosaic diploid/tetraploid pattern appears to be within the normal range (Munné et al., 1995; Bielanska et al., 2002; Clouston et al., 2002) . For chromosome 8 and 9, 1 and 8% of the nuclei were consistent with trisomy 8 and monosomy 9, respectively. Furthermore, the gestational sac in toto was isolated, but no DNA could be extracted.
Discussion
Whereas arrays have been applied to detect whole and segmental chromosomal imbalances in single cells Fiegler et al., 2007; Iwamoto et al., 2007; Hellani et al., 2008; Geigl et al., 2009; Vanneste et al., 2009a; Handyside et al., 2010; Johnson et al., 2010; Treff et al., 2010) , this is the first report describing the use of aCGH to perform PGD for infertile couples carrying CRs.
In contrast to the limited number of loci that can be studied simultaneously by PGD using FISH, aCGH allows several thousands of targets to be analysed in a single experiment. As a consequence, single-cell aCGH could become a generic PGD technique for translocation carriers, eliminating the family-specific optimization required for PGD based upon FISH (Scriven et al., 1998) . In this study, all 16 biopsied embryos could be analysed using single-cell BAC aCGH. Moreover, the meiotically derived segmental deletions and duplications could be identified: the reliability of detecting the latter using our single-cell BAC aCGH approach was calculated based on the SNP array confirmation results on 21 out of 31 blastomeres (Table II) and reinforced by FISH analysis. The sensitivity was found to be 100% (117/117; 95% CI: 96.0-100%), while the specificity was 88.8% (48/54; 95% CI: 76.7 -95.4%) since four deletions of the inserted locus and two duplications of the 14q13-qter segment were detected using the SNP-array but missed using the BAC-array. Previously, about 30% of the blastomeres could not be analysed owing to a high SD observed on the arrays. It was suggested that this high SD resulted from cells in S-phase (Vanneste et al., 2009a) . In this study, the SD of all blastomeres was within normal range and all cells could be analysed, thus significantly improving the diagnostic yield. One plausible explanation for this improved analysis rate is that the biopsy was performed in the morning of Day 3 whereas in the previous study blastomeres were picked in the evening of Day 3 or the morning of Day 4 after fertilization. Since the specificity of the single-cell BAC array approach (88.8%) is at best similar to the 90-95% accuracy of multi-probe FISH (Sermon et al., 2004) , the expected superiority of the current array approach over FISH for the detection of CRs can be questioned. The six Figure 2 Example of a deletion of the inserted region. An example of a deletion of the inserted region present in embryo 6, blastomere 2, from cycle 2, representing the paternal inheritance of a derivative chromosome 2 combined with a normal chromosome 3 is shown. (A) The mean normalized log 2 -ratio values per region (all regions are indicated on the chromosome ideograph, while the number of clones in each region can be found in Fig. 1 ) on chromosome 2. The mean value of the inserted region is 20.53 indicating that this region is deleted; while the mean values for the diploid p-and q-terminal region are 0.10 and 0.12, respectively. (B) The FISH confirmation: only one signal for probe RP11-11G20 (spectrum orange) is visualized in each nucleus, while two signals can be counted for the green labelled probe mix located at the q-terminal part of chromosome 2. (C) Represents the SNP array confirmation. From top to bottom is shown: a chromosome ideograph, the copy number (yellow ¼ 2 copies; light blue ¼ 1 copy) and the LOH bar (LOH regions are indicated in orange). (D) The parent-of-origin analysis indicates that at the side of the insertion the paternal allele (blue) is lost underpinning the presence of a paternal derivative chromosome 2.
aberrations that were missed using single-cell BAC aCGH necessitate two cell biopsy to reduce the risk for misdiagnoses. Moreover, an independent validation, preferably within the PGD time scheme, is essential. As single-cell SNP arrays allow an internal (and independent) confirmation of the results by combining the copy number analysis with LOH screening, its specificity can expected to be higher. If also the parents can be analysed on the SNP array, the parent-of-origin analysis can be used as well to ameliorate the specificity of single-cell array analysis. However, currently, the SNP array protocol is too time consuming to be implemented for PGD. In time, alternative amplification methods, segmentation algorithms and high-resolution array platforms are likely to be developed, thus enabling PGD with a higher specificity and sensitivity.
Screening using array technology not only reveals the copy number status of the chromosomal regions involved in the CCR, but also of all chromosomes, genome-wide. Only 3 out of 16 embryos were diploid, while in 11 embryos both blastomeres were different (Table III) . This high frequency of mitotic chromosome instability confirms previous observations of whole chromosome mosaicisms in cleavage-stage embryos (Munné et al., 1994; Delhanty and Handyside, 1995; Kuo et al., 1998; Daphnis et al., 2005; Vanneste et al., 2009a) . Three embryos with whole and segmental chromosomal imbalances and two embryos with only segmental imbalances further reinforce a high incidence of segmental imbalances (Voullaire et al., 2000 (Voullaire et al., , 2002 Wells and Delhanty, 2000; Wilton et al., 2003; Daphnis et al., 2008; Rius et al., 2010) .
The majority of de novo whole chromosome as well as segmental imbalances are believed to result in implantation failure of the embryo or will cause a miscarriage (as reviewed by Wilton, 2005) . However, at least some mosaic diploid/aneuploid embryos may result in chromosomally normal fetuses, following self-correction and/or self-selection mechanisms (Mantel et al., 2007; Thompson and Compton, 2010; Johnson et al., 2010) . Here, both transferred embryos had chromosomal imbalances outside the targeted loci and one transfer resulted in a pregnancy, although not to term. We provide here, for the first time, evidence for a different genomic constitution of the biopsied blastomere(s) compared with the extraembryonic tissue following hystero-embryoscopy of an embryo undergoing PGD. When considering embryo transfer, the information on the chromosomes not involved in the CR(s) tested for might be taken into account. However, stipulating the influence and interpretation procedure of imbalances on chromosomes not involved in the CR(s) tested for remains a challenge at the medical, ethical, social and psychological level, and should be the subject of a social debate (De Wert, 2009 ).
In conclusion, we demonstrate that single-cell microarray analysis enables us to test against the transmission of the unbalanced meiotic products that can derive from (complex) CRs. The BAC array result is shown per blastomere (blastomere 1/blastomere 2). The embryos for which SNP array analysis was performed to confirm the blastomere-specific results are indicated by SNP and discordances between the BAC and SNP array are shown by an *, meaning that the aberration was missed by the BAC array, but picked up by the SNP array copy number and LOH analysis. For embryo 1 in the first cycle, only one blastomere was available following amplification (**). The abbreviations used are: Nr, number; Abnl, abnormal; Mos, mosaic; Nl, normal diploid; del, deletion; null, nullisomy; ET, embryo was transferred.
technical and ethical point of view, some issues remain to be optimized or clarified before FISH can be replaced by arrays for PGD.
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